microrna profiling

Abcam is hosting a free webinar titled “Developing durable miRNA biomarker technologies for microbial carcinogenesis in resource poor settings”.

Live Webinar Details

Wednesday, November 4, 2015
16:00-17:00 CET/ 15:00-16:00 GMT/ 10:00-11:00 EST/ 07:00-08:00 PST

Register here: http://www.abcam.com/mirnaprofilingwebinar

Webinar Summary:

Currently, more than half of the global cancer burden occurs in low-and middle-income countries, with 40% of those cancers related to infection. MicroRNA profiling has tremendous potential for the diagnosis and prognosis of a broad range of these cancers, as miRNA remains stable in many accessible sample matrices- such as blood, urine, saliva, and tissue- making them ideal biomarkers.

The full promise of miRNA profiling has yet to be realized, largely due to the limited throughput of existing technologies, lack of compatibility with samples containing PCR inhibitors, and errors introduced during sample preparation.

However, as Jordan Plieskatt and lab have seen in their work on NPC and CCA, while there are several multiplexing technologies for miRNA [click to continue…]


SomaGenics LogoSANTA CRUZ, Calif., Dec. 18, 2014 /PRNewswire/ — SomaGenics has recently been awarded $2,275,000 in Small Business Innovation Research (SBIR) grants from the NIH to further develop and expand its RNA-based technologies in the areas of wound healing, hepatitis delta virus (HDV) therapeutics, microRNA (miRNA) expression profiling, and next-generation sequencing.

SomaGenics’ wound healing program is focused on treatment of chronic wounds of diabetics. These wounds, frequently occurring on the feet, are the major reason for amputations in the diabetic population and represent a large unmet medical need. SomaGenics’ new NIH funds, in the form of a Phase II SBIR grant, will [click to continue…]


Diabetes and cancer: A shared biological basis

by Christoph on September 29, 2011

in Publications

Contrary to what you might think, cancer and diabetes appear to have some biology in common. According to a report in the September 30th issue of the Cell Press journal, Cell, a pathway that initially drew attention for its role in embryonic stem cells and cancer also influences the odds that mice develop or resist diabetes.

Mice with high levels of the cancer-promoting proteins Lin28a or Lin28b become more sensitive to insulin and less prone to diabetes when on a high-fat diet, the new study shows.

“This highlights the overlap in the biology of these disorders,” said George Daley of Harvard Medical School. “It may be the same kinds of metabolic shifts that allow cancer cells to grow are also related to [whole-body] glucose metabolism.”

In fact, there were clues about such a connection, but “no obvious mechanism,” he says. For instance, studies have shown that cancer cells within a tumor are able to grow more rapidly by shifting the way they use glucose. Genome-wide association studies for type 2 diabetes have also pinpointed several susceptibility genes with known links to cancer or the cell cycle.

Daley’s team, including first authors Hau Zhu and Ng Shyh-Chang, had noticed earlier that an immature form of the microRNA (tiny bits of RNA that silence genes by targeting messenger RNA) known as let-7 is abundant in stem cells. “It allows stem cells to be stem cells,” Zhu says.

Let-7 is also important in preventing cancer, Zhu explained, and its activity is [click to continue…]


The hippocampus is a part of the brain critically involved in memory formation and spatial navigation. Shinohara et al. (2011,) used deep sequencing for  miRNA profiling of multiple samples of the mature male rat hippocampal CA3 region. According to their study, the let-7 family miRNA represents about half of the small RNA cDNA library. Major let-7 family miRNAs are  let-7c (23%), let-7a (9%), let-7f (9%), and let-7b (7%). The authors found miR134, a miRNA previously reported to be related to synaptic plasticity and morphology, only modestly expressed (~0.05%). The miRNA profiles of the left and right hippocampi were similar.  The sequence data derived from 3 pooled data sets and each data set contained corresponding left and right hippocampal CA3 samples. This study is one of the fewest studies in which miRNA expression profiles were quantitatively assessed in a specific region of the brain. The raw sequence reads and cross-mapped results are available in the DDJB sequence archive with the accession number DRA000379 (http://trace.ddbj.nig.ac.jp/DRASearch/submission?acc=DRA000379).

miRNA profiling of bilateral rat hippocampal CA3 by deep sequencing.
Shinohara Y, Yahagi K, Kawano M, Nishiyori H, Kawazu C, Suzuki N, Manabe RI, Hirase H.
Biochem Biophys Res Commun. 2011 May 13. [Epub ahead of print]
PMID:  21575607 [PubMed – as supplied by publisher]

Incoming search terms for this article:


Houston, TX (PRWEB)   –  A week after the latest miRBase update LC Sciences announced use of miRBase Version 17 probe content as new default for their miRNA microarrays. Arrays for all species included in the latest miRBase 17 release are available. Looking at the most common species: while the changes in probe content for rat are negligible, additions to the list of human miRNAs are substantial: 521 new unique human mature miRNA sequences were added (see our post miRBase Version 17 Update Released).

The full press release: http://www.prweb.com/releases/2011/5/prweb8404968.htm


MicroRNA-451 functions as a tumor suppressor in human non-small cell lung cancer by targeting ras-related protein 14 (RAB14)

March 3, 2011

Accumulating evidence suggests that microRNAs (miRNAs) are important gene regulators, which can have critical roles in diverse biological processes including tumorigenesis. In this study, researchers from Nanjing University School of Medicine analyzed the miRNA expression profiles in non-small cell lung carcinoma (NSCLC) by use of a miRNA microarray platform and identified 40 differentially expressed miRNAs. […]

Read the full article →

Accurate Molecular Classification of Kidney Cancer Subtypes Using MicroRNA Signature

January 21, 2011

Renal cell carcinoma (RCC) represents a spectrum of histologic subtypes that are morphologically and cytogenetically distinct. Distinguishing RCC subtypes is of clinical importance because they have different prognoses and subsequently different management plans. Attempts to distinguishing between the subtypes are usually made by morphologic assessment, which is often inconclusive and not always accurate. This can […]

Read the full article →

Upcoming miRNA Conference: microRNA in Human Disease & Development

February 16, 2010

Monday, March 22nd – Wednesday, March 24 – 2010 in Cambridge, MA – USA miRNA as Diagnostic Biomarkers and Targets for Therapeutic Development TOPICS INCLUDE: microRNA in Cancer microRNA in Biomarker and Diagnostic Development microRNA in Therapeutic Development microRNA in Human Development and Disease microRNA Pathways and Mechanisms PRE-CONFERENCE SHORT COURSE: microRNA Identification, Profiling and […]

Read the full article →

MicroRNA Profiling and Head and Neck Cancer

September 25, 2009

Recent advances in microRNA expression profiling have led to a better understanding of the HNOC pathogenesis. This will lead to the identification of specific microRNA expression patterns that may become powerful biomarkers for diagnosis and prognosis of HNOC. In addition, these microRNAs may also serve as therapeutic targets for novel strategies of HNOC prevention and […]

Read the full article →